Researchers at King’s College London have discovered a groundbreaking asthma treatment, Benralizumab, the first of its kind in 50 years, reducing inflammation and lung damage. The injection targets eosinophils, showing potential to prevent around two million attacks annually in the UK. Volunteers reported symptom improvement and better quality of life with few side effects. Researchers at King’s College London have discovered a groundbreaking asthma treatment, Benralizumab, the first of its kind in 50 years, reducing inflammation and lung damage. The injection targets eosinophils, showing potential to prevent around two million attacks annually in the UK. Volunteers reported symptom improvement and better quality of life with few side effects. Health and Fitness, Health Tips, Exercises & Workout Tips, Diet & Wellness | Times of India Lifestyle
